[Form 3] Immatics N.V. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Immatics N.V. executive Jordan Zeik Silverstein, Head of Strategy, reported his beneficial holdings of the company’s securities. The filing lists multiple stock option awards over Ordinary Shares at exercise prices ranging from $1.1700 to $11.0000, with expirations from 2028 through 2036, alongside 50,000 restricted stock units and 7,826 Ordinary Shares held directly. Footnotes explain that one option grant is fully vested and others, as well as the RSUs, vest in scheduled installments over several years.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Silverstein Jordan Zeik

(Last) (First) (Middle)

PAUL-EHRLICH-STR. 15

(Street)

TUBINGEN 72076

(City) (State) (Zip)

GERMANY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Immatics N.V. [ IMTX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Head of Strategy

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	7,826	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	01/01/2028	Ordinary Shares	53,031	$1.17	D
Stock Option (Right to Buy)	(1)	06/30/2030	Ordinary Shares	44,652	$10	D
Stock Option (Right to Buy)	(2)	06/30/2030	Ordinary Shares	150,000	$10	D
Stock Option (Right to Buy)	(1)	12/17/2030	Ordinary Shares	29,000	$9.68	D
Stock Option (Right to Buy)	(1)	12/08/2031	Ordinary Shares	60,000	$11	D
Stock Option (Right to Buy)	(3)	12/12/2032	Ordinary Shares	112,500	$9.75	D
Stock Option (Right to Buy)	(4)	12/04/2033	Ordinary Shares	115,000	$9.06	D
Stock Option (Right to Buy)	(5)	12/02/2034	Ordinary Shares	110,000	$8.06	D
Stock Option (Right to Buy)	(6)	01/07/2036	Ordinary Shares	200,000	$9.32	D
Restricted Stock Units	(7)	(7)	Ordinary Shares	50,000	$0	D

Explanation of Responses:

1. These options to purchase ordinary shares of the Issuer ("Ordinary Shares," and each such option, an "Option") are fully vested.

2. These Options are eligible to be earned based on the achievement of specified market capitalization performance hurdles and service-vesting conditions. The service-vesting conditions are satisfied as to 25% of the Options on the first anniversary of the grant date, June 30, 2020, and 6.25% of the Options on each quarterly anniversary of such date over the following three years.

3. These Options vest 25% on the first anniversary of the grant date, December 13, 2022, then in 12 equal quarterly installments over the following three years.

4. These Options vest 25% on the first anniversary of the grant date, December 5, 2023, then in 12 equal quarterly installments over the following three years.

5. These Options vest 25% on the first anniversary of the grant date, December 3, 2024, then in 12 equal quarterly installments over the following three years.

6. These Options vest 25% on the first anniversary of the grant date, January 8, 2026, then in 12 equal quarterly installments over the following three years.

7. Each restricted stock unit ("RSU") represents a contingent right to receive one Ordinary Share. These RSUs vest in four equal annual installments on each anniversary of the grant date, January 8, 2026.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney

	/s/ Edward Sturchio, attorney-in-fact for Jordan Zeik Silverstein	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What insider position does Jordan Zeik Silverstein hold at Immatics (IMTX)?

Jordan Zeik Silverstein is an officer at Immatics N.V., serving as Head of Strategy. The Form 3 filing lists his beneficial holdings, including stock options, restricted stock units, and directly owned Ordinary Shares in the company.

What types of Immatics (IMTX) securities does Jordan Zeik Silverstein hold?

Jordan Zeik Silverstein holds Ordinary Shares, multiple stock options (rights to buy) over Ordinary Shares at various exercise prices and expirations, and 50,000 restricted stock units that convert into Ordinary Shares upon vesting.

How many Immatics (IMTX) Ordinary Shares does Jordan Zeik Silverstein own directly?

The filing shows Jordan Zeik Silverstein directly holding 7,826 Ordinary Shares of Immatics N.V. This is in addition to his stock options and restricted stock units linked to additional Ordinary Shares of the company.

What are the key Immatics (IMTX) stock option awards held by Jordan Zeik Silverstein?

He holds several stock option grants over Immatics Ordinary Shares, including an award for 200,000 shares at an exercise price of $9.3200 expiring on January 7, 2036, plus other grants at exercise prices from $1.1700 to $11.0000.

How do Jordan Zeik Silverstein’s Immatics (IMTX) options and RSUs vest?

Footnotes state some options are fully vested, while others vest 25% on the first anniversary of their grant dates, then in equal quarterly installments over three years. The 50,000 RSUs vest in four equal annual installments from January 8, 2026.

What does each Immatics (IMTX) restricted stock unit represent in this filing?

Each restricted stock unit, or RSU, represents a contingent right to receive one Ordinary Share of Immatics N.V. The filing shows 50,000 RSUs, which vest in four equal annual installments starting on January 8, 2026.